Deka Bank Deutsche Girozentrale 10x Genomics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 2,027 shares of TXG stock, worth $32,148. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,027

Previous 2,027 -0.0%

Holding current value

$32,148

Previous $39,000 15.38%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$40.86 - $62.98 $1.14 Million - $1.76 Million	-27,973 Reduced 93.24%	2,027 $84,000
Q4 2022 Feb 01, 2023	SELL	$24.4 - $41.3 $183,000 - $309,750	-7,500 Reduced 20.0%	30,000 $1.09 Million
Q3 2022 Nov 02, 2022	SELL	$28.48 - $52.59 $2 Million - $3.7 Million	-70,300 Reduced 65.21%	37,500 $1.11 Million
Q2 2022 Aug 03, 2022	BUY	$36.95 - $82.41 $2.48 Million - $5.53 Million	67,113 Added 164.95%	107,800 $4.89 Million
Q1 2022 Apr 28, 2022	BUY	$55.7 - $145.79 $481,136 - $1.26 Million	8,638 Added 26.95%	40,687 $3.13 Million
Q4 2021 Feb 02, 2022	SELL	$135.05 - $182.59 $1.8 Million - $2.43 Million	-13,330 Reduced 29.37%	32,049 $4.62 Million
Q3 2021 Oct 22, 2021	BUY	$145.58 - $192.14 $5.61 Million - $7.4 Million	38,505 Added 560.15%	45,379 $6.61 Million
Q2 2021 Aug 05, 2021	BUY	$134.22 - $202.37 $451,247 - $680,367	3,362 Added 95.73%	6,874 $1.37 Million
Q1 2021 Apr 28, 2021	BUY	$140.25 - $196.86 $1,823 - $2,559	13 Added 0.37%	3,512 $589,000
Q4 2020 Mar 12, 2021	BUY	$126.47 - $163.7 $442,518 - $572,786	3,499 New	3,499 $496,000

Others Institutions Holding TXG

# of Institutions

285

Shares Held

95.8M

Call Options Held

162K

Put Options Held

107K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.51B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale 10x Genomics, Inc. Transaction History